IRIS Accounts Production v24.3.0.553 10557856 director 1.2.23 31.1.24 31.1.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh105578562023-01-31105578562024-01-31105578562023-02-012024-01-31105578562022-01-31105578562022-02-012023-01-31105578562023-01-3110557856ns15:EnglandWales2023-02-012024-01-3110557856ns14:PoundSterling2023-02-012024-01-3110557856ns10:Director12023-02-012024-01-3110557856ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3110557856ns10:SmallEntities2023-02-012024-01-3110557856ns10:AuditExemptWithAccountantsReport2023-02-012024-01-3110557856ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3110557856ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3110557856ns10:FullAccounts2023-02-012024-01-311055785612023-02-012024-01-3110557856ns10:RegisteredOffice2023-02-012024-01-3110557856ns5:CurrentFinancialInstruments2024-01-3110557856ns5:CurrentFinancialInstruments2023-01-3110557856ns5:ShareCapital2024-01-3110557856ns5:ShareCapital2023-01-3110557856ns5:RetainedEarningsAccumulatedLosses2024-01-3110557856ns5:RetainedEarningsAccumulatedLosses2023-01-3110557856ns5:NetGoodwill2023-02-012024-01-3110557856ns5:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3110557856ns5:PlantMachinery2023-02-012024-01-3110557856ns5:MotorVehicles2023-02-012024-01-3110557856ns5:ComputerEquipment2023-02-012024-01-3110557856ns5:NetGoodwill2023-01-3110557856ns5:NetGoodwill2024-01-3110557856ns5:NetGoodwill2023-01-3110557856ns5:PlantMachinery2023-01-3110557856ns5:MotorVehicles2023-01-3110557856ns5:ComputerEquipment2023-01-3110557856ns5:PlantMachinery2024-01-3110557856ns5:MotorVehicles2024-01-3110557856ns5:ComputerEquipment2024-01-3110557856ns5:PlantMachinery2023-01-3110557856ns5:MotorVehicles2023-01-3110557856ns5:ComputerEquipment2023-01-3110557856ns5:CostValuation2023-01-3110557856ns5:RevaluationsIncreaseDecreaseInInvestments2024-01-3110557856ns5:CostValuation2024-01-3110557856ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3110557856ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-31
REGISTERED NUMBER: 10557856 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Wilkinson Orthopaedics Limited

Wilkinson Orthopaedics Limited (Registered number: 10557856)

Contents of the Financial Statements
for the Year Ended 31 January 2024










Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 5


Wilkinson Orthopaedics Limited

Company Information
for the Year Ended 31 January 2024







DIRECTOR: J M Wilkinson



REGISTERED OFFICE: 9 Chorley Road
Fulwood
Sheffield
South Yorkshire
S10 3RJ



REGISTERED NUMBER: 10557856 (England and Wales)



ACCOUNTANTS: Landin Wilcock & Co
Chartered Accountants
68 Queen Street
Sheffield
South Yorkshire
S1 1WR



BANKERS: HSBC
Unit 3 Carmel House
49-63 Fargate
Sheffield
South Yorkshire
S1 2HD

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Wilkinson Orthopaedics Limited


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Director's Report are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Wilkinson Orthopaedics Limited for the year ended 31 January 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Wilkinson Orthopaedics Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Wilkinson Orthopaedics Limited and state those matters that we have agreed to state to the director of Wilkinson Orthopaedics Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Wilkinson Orthopaedics Limited and its director for our work or for this report.

It is your duty to ensure that Wilkinson Orthopaedics Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Wilkinson Orthopaedics Limited. You consider that Wilkinson Orthopaedics Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Wilkinson Orthopaedics Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Landin Wilcock & Co
Chartered Accountants
68 Queen Street
Sheffield
South Yorkshire
S1 1WR


24 October 2024

Wilkinson Orthopaedics Limited (Registered number: 10557856)

Balance Sheet
31 January 2024

31/1/24 31/1/23
Notes £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 69,106 94,112
Investments 6 179,149 167,432
248,255 261,544

CURRENT ASSETS
Debtors 7 29,916 19,063
Cash at bank and in hand 320,301 171,767
350,217 190,830
CREDITORS
Amounts falling due within one year 8 (64,952 ) (28,781 )
NET CURRENT ASSETS 285,265 162,049
TOTAL ASSETS LESS CURRENT LIABILITIES 533,520 423,593

PROVISIONS FOR LIABILITIES - (517 )
NET ASSETS 533,520 423,076

CAPITAL AND RESERVES
Called up share capital 50 50
Retained earnings 533,470 423,026
533,520 423,076

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Wilkinson Orthopaedics Limited (Registered number: 10557856)

Balance Sheet - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 October 2024 and were signed by:





J M Wilkinson - Director


Wilkinson Orthopaedics Limited (Registered number: 10557856)

Notes to the Financial Statements
for the Year Ended 31 January 2024


1. STATUTORY INFORMATION

Wilkinson Orthopaedics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2017, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Motor vehicles - 20% on reducing balance
Computer equipment - 33% on cost

Tangible fixed assets are initially measured at cost. Subsequently, they are measured at cost less accumulated depreciation and impairment losses.

Financial instruments
Financial assets and financial liabilities are recognised when the Company becomes party to the contractual provisions of the instrument. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Wilkinson Orthopaedics Limited (Registered number: 10557856)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2023
and 31 January 2024 11,000
AMORTISATION
At 1 February 2023
and 31 January 2024 11,000
NET BOOK VALUE
At 31 January 2024 -
At 31 January 2023 -

5. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 February 2023
and 31 January 2024 20,710 97,918 1,457 120,085
DEPRECIATION
At 1 February 2023 5,178 19,584 1,211 25,973
Charge for year 5,177 19,583 246 25,006
At 31 January 2024 10,355 39,167 1,457 50,979
NET BOOK VALUE
At 31 January 2024 10,355 58,751 - 69,106
At 31 January 2023 15,532 78,334 246 94,112

Wilkinson Orthopaedics Limited (Registered number: 10557856)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024


6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 February 2023 167,432
Revaluations 11,717
At 31 January 2024 179,149
NET BOOK VALUE
At 31 January 2024 179,149
At 31 January 2023 167,432

Cost or valuation at 31 January 2024 is represented by:

Other
investments
£   
Valuation in 2021 282
Valuation in 2022 7,841
Valuation in 2023 (3,691 )
Valuation in 2024 11,717
Cost 163,000
179,149

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/1/24 31/1/23
£    £   
Trade debtors 26,916 16,063
Other debtors 3,000 3,000
29,916 19,063

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/1/24 31/1/23
£    £   
Taxation and social security 52,636 27,174
Other creditors 12,316 1,607
64,952 28,781